Acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia. Methylthioninium chloride Proveblue is indicated in adults, children and adolescents (aged 0 to 17 years old).
Theranica announced that the FDA granted a De Novo request for its smartphone-controlled electroceutical, Nerivio Migra, utilizing Remote Electrical Neuromodulation...
Scopio Labs, developer of Full-Field Digital Cell Morphology imaging and analysis platforms and a recognized leader in digital morphology, announced that it has been granted De Novo clearance by the FDA for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
The purpose of this study was to evaluate whether delayed (i.e. 28 ± 4 days post-transplant) administration of everolimus after transplantation reduces the risk of wound healing complications in comparison with...
Veloxis Pharmaceuticals announced that the FDA approved a new indication for Envarsus XR (tacrolimus extended-release tablets) to prevent organ rejection...
This study was designed to evaluate the renal function comparing Certican based immunosuppressive regimens with two different CNIs (Tacrolimus or Cyclosporin A) versus a standard treatment with Mycophenolic Acid and Tacrolimus in de novo renal transplant recipients.
A randomized controlled study to assess the safety and efficacy and overall benefit of FCR001 cell therapy in de novo living donor renal transplantation.